Every day, people like you choose MD Anderson for cancer treatment. But it’s more than our decades of experience, top national rankings and leadership in cancer prevention that set us apart. It goes beyond our groundbreaking research and innovative clinical care that provide new therapies years before they become standard in the community.

The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Call us at 1-877-632-6789 or. request an appointment online. MD Anderson is located in the heart of the Texas Medical Center, just minutes from downtown Houston. What began in 1941 on the grounds of a Houston estate has grown to more than a dozen buildings dedicated to world-class patient care and research.

Created by the Texas Legislature in 1941 as part of The University of Texas System, MD Anderson is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971. It exclusively focuses on cancer, with the mission to end cancer for patients and their families in Texas, the nation, and the world.

Our nationally recognized cancer program delivers the highest level of care close to home. You receive coordinated services therapies that are among the most advanced.

Discover exceptional cancer care at the MD Anderson Cancer Center at Cooper. Contact us today to learn more about our expert treatments and services.

Learn about the various types of cancer treated at MD Anderson, including information about symptoms, methods used in diagnosis, staging, treatment and more.

At MD Anderson Cancer Center at Cooper, our Division of Hematology and Medical Oncology specializes in the diagnosis, treatment, and medical management of all types of cancer and blood disorders. Here, doctors with different areas of expertise work together to develop a comprehensive evaluation and an individualized treatment plan for you.

2 天之前 · MDA-MB-436 is a widely studied breast cancer cell line known for its BRCA1 deficiency, making it valuable for research on triple-negative breast cancer and DNA repair mechanisms. Its genetic profile has made it a key model for investigating tumor biology and therapeutic strategies targeting BRCA1-mutant cancers.

2 天之前 · It was Story’s good fortune, then, that Dr. Michael Overman, an oncologist at MD Anderson who focuses on pancreatic and intestinal tumors, had recently encountered a superdonor: an elderly woman ...